These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2150472)

  • 1. [Remission of left ventricular hypertrophy of hypertensive origin. Experimental data].
    Contard F; Rappaport L; Samuel JL; Swynghedauw B
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():27-30. PubMed ID: 2150472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antihypertensive treatment and remission of left ventricular hypertrophy. Critical study].
    Clémenty J; Dulhoste MN; Bordier P; Lartigue MC; Pons N
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():39-43. PubMed ID: 2150473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is secondary myocardial hypertrophy a physiological or pathological adaptive mechanism?].
    Krayenbühl HP
    Z Kardiol; 1982 Aug; 71(8):489-96. PubMed ID: 6215776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Left ventricular remodeling and hypertension. Course with antihypertensive therapy].
    Ollivier JP
    Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():73-7. PubMed ID: 1838922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The heart in patients with hypertension: effects of rilmenidine on experimental cardiac hypertrophy of hypertensive origin in rats].
    Callens-el Amrani F; Paolaggi F; Swynghedauw B
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():53-7. PubMed ID: 2534268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of renin-angiotensin system activity to left ventricular hypertrophy and function in experimental and human hypertension.
    Devereux RB; Pickering TG; Cody RJ; Laragh JH
    J Clin Hypertens; 1987 Mar; 3(1):87-103. PubMed ID: 3033158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac function as related to adrenergic activity in hypertensive left ventricular hypertrophy.
    Agabiti-Rosei E; Muiesan ML; Romanelli G; Castellano M; Beschi M; Alicandri C; Muiesan G
    J Clin Hypertens; 1987 Jun; 3(2):203-10. PubMed ID: 3039076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphologic findings during regression of heart hypertrophy].
    Frenzel H
    Z Kardiol; 1985; 74 Suppl 7():107-18. PubMed ID: 2936013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of the cardiac renin-angiotensin system in hypertensive heart disease].
    Holmer SR; Riegger GA
    Herz; 1995 Oct; 20(5):322-9. PubMed ID: 7498879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
    Klaus D
    Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of cardiac myocytes and non-myocytes in mechanical stress-induced hypertrophy.
    Yamazaki T; Shiojima I; Komuro I; Nagai R; Yazaki Y
    Herz; 1995 Apr; 20(2):109-17. PubMed ID: 7774862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypertensive cardiopathy--an adaptive or a pathologic phenomenon?].
    Roşu D; Streian C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(4):307-18. PubMed ID: 2573941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
    Strauer BE; Bayer F; Brecht HM; Motz W
    J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Left-ventricular hypertrophy as a cardiac risk factor: role of the renin-angiotensin-aldosterone system].
    Erne P
    Praxis (Bern 1994); 1996 Feb; 85(8):227-33. PubMed ID: 8701189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major new developments affecting treatment and prognosis in hypertension.
    Gubner RS
    Trans Assoc Life Insur Med Dir Am; 1990; 73():97-114. PubMed ID: 2353405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiological considerations in left ventricular hypertrophy.
    Frohlich ED
    J Clin Hypertens; 1987 Mar; 3(1):54-65. PubMed ID: 2952767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk for cardiac involvement in essential hypertension.
    Zahka KG
    Cardiol Clin; 1986 Feb; 4(1):81-93. PubMed ID: 2939953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remodeling of the heart (membrane proteins and collagen) in hypertensive cardiopathy.
    Sainte Beuve C; Leclercq C; Rannou F; Oliviero P; Mansier P; Chevalier B; Swynghedauw B; Charlemagne D
    Kidney Int Suppl; 1992 Jun; 37():S45-50. PubMed ID: 1385839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of ventricular hypertrophy and fibrosis in rats by pitavastatin: potential role of the RhoA-extracellular signal-regulated kinase-serum response factor signalling pathway.
    Saka M; Obata K; Ichihara S; Cheng XW; Kimata H; Noda A; Izawa H; Nagata K; Yokota M
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1164-71. PubMed ID: 17184496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.